Day One Biopharma to be acquired by Servier for $2.5B
Source: SeekingAlpha
2026-03-06 09:07:21 ET
More on Day One Biopharmaceuticals
- Day One Biopharmaceuticals: 'Strong Buy,' Several 2026 Milestones In Play Plus OJEMDA Growth
- Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead
- Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript
- Day One Biopharmaceuticals gains amid takeover speculation
- Day One Biopharmaceuticals reiterates $225M–$250M OJEMDA revenue target as pipeline expands with Emi-Le integration
Read the full article on Seeking Alpha
For further details see:
Day One Biopharma to be acquired by Servier for $2.5B
Ipsen ADR
NASDAQ: IPSEY
IPSEY Trading
0.0% G/L:
$46.31 Last:
4,394 Volume:
$46.31 Open:
IPSEY Latest News
December 07, 2025 05:33:00 pm
ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025
December 05, 2025 05:00:00 am
ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting
June 02, 2025 08:00:00 am
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
